K Vitaminin Kemik ve Kardiyovasküler Sistem Üzerine Etkilerinin İncelenmesi
Özet
K vitamini, pıhtılaşma faktörlerinin sentezindeki temel rolünün yanı sıra kemik mineralizasyonu ve kardiyovasküler sağlık üzerinde kritik fonksiyonlara sahiptir. Kemik dokusunda osteoblast aktivitesini artırıp osteoklastları baskılayarak osteoporoz ve kırık riskini azaltırken, damar duvarlarında kalsiyum birikimini önleyerek arteriyel sertleşmeye karşı koruma sağlar. Özellikle K2 vitamini formu, vasküler kalsifikasyonu inhibe eden proteinleri aktive ederek koroner kalp hastalığı riskini düşürmede etkili bir kofaktör olarak öne çıkar.
Vitamin K serves as a vital cofactor for proteins involved in blood coagulation, bone metabolism, and cardiovascular health. It promotes bone formation by enhancing osteoblast activity and reducing bone resorption, which significantly lowers the risk of osteoporosis and fractures. Furthermore, it helps prevent vascular calcification by activating matrix Gla protein, thereby protecting against arterial stiffness and reducing the risk of coronary heart disease.
Referanslar
Additives JFWECoF, Meeting JFWECoFA, Organization WH. Evaluation of Certain Food Additives and Contaminants: Fifty-seventh Report of the Joint FAO/WHO Expert Committee on Food Additives: World Health Organization; 2002.
Booth SL, Saltzman E. Vitamin K: Structure and function. eLS. 2001.
Heird W. Vitamin deficiencies and excesses. Behrman RE, Kliegman RM, Jenson HB Nelson txtbook of pediatrics 17th ed Philadelphia: Saunders. 2004:177-90.
Higdon J. An evidence-based approach to vitamins and minerals health benefits and intake recommendations: Thieme Medical Publishers, Inc.; 2003.
Küçük BB. Fare Trombositlerinde Gas 6 (Growth Arrest Spesific-6) varlığının araştırılması: Marmara Universitesi (Turkey); 2011.
Langman M. Part 2 Fat soluble Vitamins: Vitamin K. Expert Group on Vitamins and Minerals Safe Upper Levels for Vitamins and Minerals. 2003:154-61.
Zipursky A. Prevention of vitamin K deficiency bleeding in newborns. British journal of haematology. 1999;104(3):430-7. DOI: 10.1046/j.1365-2141.1999.01104.x
Greer F. Vitamin K status of lactating mothers and their infants. Acta Pædiatrica. 1999;88:95-103. https://doi.org/10.1111/j.1651-2227.1999.tb01308.x
Isarangkura P, Mahasandana C, Chuansumrit A, Angchaisuksiri P. Acquired bleeding disorders: the impact of health problems in the developing world. Haemophilia. 2004;10:188-95. https://doi.org/10.1111/j.1365-2516.2004.01008.x
SO. K. Rasyonel Tedavi Yönünden Tıbbi Farmakoloji. Hacettepe-Taş, editor. Ankara2002. 1480-4. p.
Schurgers L, Geleijnse J, Grobbee D, Pols H, Hofman A, Witteman J, et al. Nutritional intake of vitamins K1 (phylloquinone) and K2 (menaquinone) in the Netherlands. Journal of nutritional & environmental medicine. 1999;9(2):115-22. https://doi.org/10.1080/13590849961717
Shearer M. Vitamin K. The Lancet. 1995;345(8944):229-34.
Kohlmeier M, Salomon A, Saupe J, Shearer MJ. Transport of vitamin K to bone in humans. The Journal of nutrition. 1996;126(suppl_4):1192S-6S. https://doi.org/10.1093/jn/126.suppl_4.1192S
Usui Y, Tanimura H, Nishimura N, Kobayashi N, Okanoue T, Ozawa K. Vitamin K concentrations in the plasma and liver of surgical patients. The American journal of clinical nutrition. 1990;51(5):846-52. https://doi.org/10.1093/ajcn/51.5.846
Booth SL, Broe KE, Gagnon DR, Tucker KL, Hannan MT, McLean RR, et al. Vitamin K intake and bone mineral density in women and men. The American journal of clinical nutrition. 2003;77(2):512-6. https://doi.org/10.1093/ajcn/77.2.512
http://www.vitaspace.com/vitamin_k2.htm.
Orimo H, Shiraki M, Tomita A, Morii H, Fujita T, Ohata M. Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: a double-blind placebo-controlled study. Journal of bone and mineral metabolism. 1998;16(2):106-12.
Takeuchi Y, Suzawa M, Fukumoto S, Fujita T. Vitamin K2 inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures. Bone. 2000;27(6):769-76. https://doi.org/10.1016/S8756-3282(00)00396-3Get rights and content
Beulens JW, Bots ML, Atsma F, Bartelink M-LE, Prokop M, Geleijnse JM, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009;203(2):489-93. https://doi.org/10.1016/j.atherosclerosis.2008.07.010
Ercan S. Steroid kaynaklı osteonekroza vitamin Knın etkisi.
Fried D, Seligsohn U, Gottlieb A, Raviv U. Late onset of hemorrhagic disease of the newborn. Harefuah. 1977;92(12):565-6.
Bouckaert J, Said A. Fracture healing by vitamin K. Nature. 1960;185(4716):849-.
Hart J, Shearer M, Klenerman L, Catterall A, Reeve J, Sambrook P, et al. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 1985;60(6):1268-9. https://doi.org/10.1210/jcem-60-6-1268
Bitensky L, Hart J, Catterall A, Hodges S, Pilkington M, Chayen J. Circulating vitamin K levels in patients with fractures. The Journal of Bone and Joint Surgery British volume. 1988;70(4):663-4. https://doi.org/10.1302/0301-620X.70B4.3403621
Hodges S, Akesson K, Vergnaud P, Obrant K, Delmas P. Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. Journal of bone and mineral research. 1993;8(10):1241-5. https://doi.org/10.1002/jbmr.5650081012
Cham BE, Smith JL, Colquhoun DM. What happens to vitamin K1 in serum after bone fracture? Clinical chemistry. 1999;45(12):2261-3. https://doi.org/10.1093/clinchem/45.12.2261
Braam L, Knapen M, Geusens P, Brouns F, Hamulyak K, Gerichhausen M, et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcified tissue international. 2003;73(1):21-6. DOI: 10.1007/s00223-002-2084-4
Setia DN, Tjahjono HA. PENGARUH PEMBERIAN VITAMIN D3 TERHADAP KADAR OSTEOKALSIN, 25 (OH) D DAN DURASI SAKIT PADA DIABETES MELLITUS TIPE 1 PADA ANAK. Majalah Kesehatan FKUB. 2019;6(2):96-105.
Shea MK, Holden RM. Vitamin K status and vascular calcification: evidence from observational and clinical studies. Advances in nutrition. 2012;3(2):158-65. https://doi.org/10.3945/an.111.001644
Folsom AR, Kronmal RA, Detrano RC, O’Leary DH, Bild DE, Bluemke DA, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Archives of internal medicine. 2008;168(12):1333-9. doi:10.1001/archinte.168.12.1333
Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. Jama. 2010;303(16):1610-6. doi:10.1001/jama.2010.461
Beulens JW, Booth SL, van den Heuvel EG, Stoecklin E, Baka A, Vermeer C. The role of menaquinones (vitamin K2) in human health. British Journal of Nutrition. 2013;110(8):1357-68. doi:10.1017/S0007114513001013
Dalmeijer GW, Van Der Schouw YT, Booth SL, De Jong PA, Beulens JW. Phylloquinone concentrations and the risk of vascular calcification in healthy women. Arteriosclerosis, Thrombosis, and Vascular Biology. 2014;34(7):1587-90. DOI 10.1007/s13668-017-0208-8
Cranenburg EC, Schurgers LJ, Vermeer C. Vitamin K: the coagulation vitamin that became omnipotent. Thrombosis and haemostasis. 2007;98(07):120-5. DOI: 10.1160/TH07-04-0266
Schurgers LJ, Teunissen KJ, Knapen MH, Kwaijtaal M, van Diest R, Appels A, et al. Novel conformation-specific antibodies against matrix γ-carboxyglutamic acid (Gla) protein: Undercarboxylated matrix Gla protein as marker for vascular calcification. Arteriosclerosis, thrombosis, and vascular biology. 2005;25(8):1629-33. https://doi.org/10.1161/01
Fu X, Wang X-D, Mernitz H, Wallin R, Shea MK, Booth SL. 9-Cis retinoic acid reduces 1 α, 25-dihydroxycholecalciferol-induced renal calcification by altering vitamin K-dependent γ-carboxylation of matrix γ-carboxyglutamic acid protein in A/J male mice. The Journal of nutrition. 2008;138(12):2337-41. https://doi.org/10.3945/jn.108.093724
Stenflo J, Fernlund P, Egan W, Roepstorff P. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proceedings of the National Academy of Sciences. 1974;71(7):2730-3. https://doi.org/10.1073/pnas.71.7.2730
Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, Van Der Meer IM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. The Journal of nutrition. 2004;134(11):3100-5. https://doi.org/10.1093/jn/134.11.3100
Gast G-CM, de Roos NM, Sluijs I, Bots ML, Beulens JW, Geleijnse JM, et al. A high menaquinone intake reduces the incidence of coronary heart disease. Nutrition, Metabolism and Cardiovascular Diseases. 2009;19(7):504-10. https://doi.org/10.1016/j.numecd.2008.10.004
Erkkilä A, Booth S, Hu F, Jacques P, Manson J, Rexrode K, et al. Phylloquinone intake as a marker for coronary heart disease risk but not stroke in women. European journal of clinical nutrition. 2005;59(2):196-204. doi:10.1038/sj.ejcn.1602058
Braam L, McKeown N, Jacques P, Lichtenstein A, Vermeer C, Wilson P, et al. Dietary phylloquinone intake as a potential marker for a heart-healthy dietary pattern in the Framingham Offspring cohort. Journal of the American Dietetic Association. 2004;104(9):1410-4. https://doi.org/10.1016/j.jada.2004.06.021
